SCHEMBL31138752

SCHEMBL31138752

Cn1cc(C(F)(F)F)nc1-c1ccc(CNc2nc(Cl)nc3ncccc23)cc1

nearest known ligand 0.44

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ USP1 O94782 19/20 0.44
▸ PDE2A O00408 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30462043 0.85 USP1 (0.46) USP1
SCHEMBL31537601 0.83 USP1 (0.45) USP1
SCHEMBL31138657 0.82 PIP4K2C (0.57) USP1
SCHEMBL31572126 0.81 PDE2A (0.46) USP1PDE2A
SCHEMBL25976056 0.80 USP1 (0.43) USP1PDE2A
SCHEMBL26627859 0.80 PDE2A (0.43) USP1PDE2A
SCHEMBL30461997 0.80 PDE2A (0.43) USP1PDE2A
SCHEMBL30462059 0.79 PDE2A (0.42) USP1PDE2A
SCHEMBL29043903 0.79 PDE2A (0.42) USP1PDE2A
SCHEMBL30462076 0.79 AGTR1 (0.41) USP1PDE2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024233605-A1 COMPOUNDS AND THEIR USE AGAINST CANCER TANGO THERAPEUTICS, INC. (US) 2024-11-14 — — WO disclosed
Send feedback